G

ood morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and refreshing, because the relentless routine of meetings, deadlines, and what-not has, predictably, returned. To cope, yes, we are quaffing cups of stimulation — vanilla macadamia nut is on top, for those tracking the variety — and, as always, we invite you to join us. Remember, no prescription is required. On that note, here are some tidbits to help you get going. Hope you have a smashing, and please keep in touch …

Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, Roche (ROG) has done an about-face and decided to make the drug available to patients for free, according to Euractive. The Greek health minister accused Roche of blackmail after the drug maker moved to withdraw a cancer drug from the market in response to mandatory discounts imposed by the government.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.